Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England.
Thomas F D MasonMatt WhitstonJack HodgsonRuth Elizabeth WatkinsonYiu-Shing LauOmnia AbdulrazegMatthew SuttonPublished in: BMC medicine (2021)
Receipt of the BNT162b2 mRNA vaccine is effective at reducing COVID-19 hospitalisations and infections. The nationwide vaccination of older adults in England with the BNT162b2 mRNA vaccine reduced the burden of COVID-19.